News

It began as a spark of interest in remote healthcare, gained momentum four years ago with the introduction of a suite of digital health services, then exploded when COVID-19 strained the system, making hospital and doctor visits anything but routine. Today, telemedicine—as a panel of experts at an Oct. 1 Weill Cornell Medicine webinar agreed—is no longer a futuristic idea but an immediate and vital tool for doctors and patients alike.

An intercampus research team at Weill Cornell Medicine and Cornell’s Ithaca campus has been awarded a five-year, $3.65 million grant from the National Institutes of Health (NIH) to develop a quick, inexpensive method for accurately diagnosing urinary tract infections in kidney transplant patients by carrying out molecular profiling of cell-free DNA in urine.

Dr. Manish A. Parikh, an internationally renowned clinical interventional cardiologist and educator, has been named chief of cardiology at NewYork-Presbyterian Brooklyn Methodist Hospital.

NewYork Quality Care, the accountable care organization (ACO) of NewYork-Presbyterian, Columbia University Irving Medical Center, and Weill Cornell Medicine, saved Medicare $23,288,625 in 2019 and improved the quality of care for Medicare beneficiaries, according to performance results recently released by the Centers for Medicare & Medicaid Services (CMS).

A long-standing debate among cardiologists comparing two common heart procedures is closer to being resolved.

The amount of SARS-CoV-2 virus, or “viral load,” in cancer patients and in the general inpatient population upon hospital admission may predict their risk of dying of the infection, according to a study led by researchers at Weill Cornell Medicine and NewYork-Presbyterian.

With the need for wide scale COVID-19 testing to allow societies reopen safely, a group from Weill Cornell Medicine and other academic medical centers and research organizations have announced the launch of a global competition for low-cost, high-quality and scalable COVID-19 tests, called the COVID-19 XPRIZE, in a letter published Aug. 20 in Nature Biotechnology.

A study by investigators at Weill Cornell Medicine and NewYork-Presbyterian aims to answer one of COVID-19’s biggest mysteries: why do some people become severely ill, while others have no symptoms?

Dr. Anna S. Nam, an assistant professor of pathology and laboratory medicine at Weill Cornell Medicine, has received a 2020 Early Independence Award from the National Institutes of Health’s (NIH) High Risk, High Reward Research program and a 2020 Burroughs Wellcome Fund Career Award for Medical Scientists. 

One of the nation’s leading colorectal surgeons, Dr. Alessio Pigazzi, has been named chief of colorectal surgery at NewYork-Presbyterian/Weill Cornell Medical Center and Weill Cornell Medicine, effective Sept. 28. He will also serve on Weill Cornell Medicine’s faculty.

The COVID-19 pandemic will potentially lead to greater disparities in cancer care and outcomes among Black and Hispanic New Yorker.

Ear, nose and throat (ENT) faculty discuss how Weill Cornell Medicine has safely and efficiently reopened outpatient otolaryngology following disruption to practice because of COVID-19.

For the third year in a row, Weill Cornell Medicine has been awarded the Health Professions Higher Education Excellence in Diversity Health Professions Award by INSIGHT Into Diversity magazine.

Cancer cells rearrange, copy, and delete their DNA in complex but distinct patterns, according to new research from a multi-institution team led by investigators at Weill Cornell Medicine and the New York Genome Center. The investigators developed sophisticated new algorithms to analyze nearly 3,000 genome sequences from human tumors.

Awards, honors, prizes and achievements for the month of September.

Neurological complications ranging from headache, malaise and loss of smell to confusion and disabling strokes have been a disturbing consequence of COVID-19.

Weill Cornell Medicine investigators have received a total of $3.5 million from the Patient-Centered Outcomes Research Institute (PCORI) to study the effectiveness of telehealth services during the COVID-19 pandemic, and to develop models that can aid in clinical decision making in the treatment of the virus.

Weill Cornell Medicine’s debt-free initiative, now a year old, expanded the institution’s scholarship offerings to provide debt-free education to all medical students with demonstrated financial need. The program replaced student loans with scholarships that cover tuition, housing and other living expenses.

As the newly appointed senior managing director with the Center for Technology Licensing (CTL) at Cornell University, Dr. Lisa Placanica will lead technology licensing efforts at Weill Cornell Medicine.

Dr. Sallie Permar, an eminent physician-scientist who focuses on the treatment and prevention of neonatal viral infections, has been appointed chair of the Department of Pediatrics at Weill Cornell Medicine and pediatrician-in-chief at NewYork-Presbyterian/Weill Cornell Medical Center and NewYork-Presbyterian Komansky Children’s Hospital